The United States faces an estimated $8 billion healthcare burden from long COVID over the next three years, according to analysis published in The Conversation. The original source indicates the nation struggles with inadequate treatment capacity and that recent HHS defunding is taking the country further away from being able to handle the growing number of long COVID cases.
Long COVID Economic Impact Components
Distribution of estimated costs over three years, billions USD
Source: The Conversation Analysis, 2024 | Georgian Medical Journal News
Treatment Capacity Crisis Deepens Financial Burden
According to The Conversation analysis, the US healthcare system lacks sufficient capacity to treat the growing population of long COVID patients. The source notes that recent federal defunding of specialized long COVID research and treatment programs has further reduced the nation’s ability to address this mounting public health challenge.
For comprehensive coverage of healthcare policy developments, visit our Health Policy section.
Workforce Impact Compounds Economic Losses
According to The Conversation analysis, the financial impact of long COVID extends beyond direct medical costs to encompass workforce productivity losses. The analysis indicates that workforce-related losses could account for a significant portion of the total economic burden, highlighting the condition’s impact beyond the healthcare sector.
Disability Claims and Social Safety Net
The Conversation analysis indicates that long COVID has implications for disability support systems, as reflected in the estimated $1.4 billion allocated to this category in the three-year cost projection.
Read more about clinical developments in our Clinical Updates coverage.
Federal Response Inadequate for Scale of Challenge
The Conversation source notes that HHS defunding is taking the country further away from being able to handle the country’s growing number of long COVID cases, despite the projected $8 billion burden over three years.
The $8 billion estimate represents costs over three years related to healthcare burden, managing symptoms and loss to the workforce.
— The Conversation Analysis, 2024
Key takeaways
- Long COVID could cost the US an estimated $8 billion over three years according to The Conversation analysis
- The US lacks capacity to treat long COVID according to the source
- HHS defunding is reducing the nation’s ability to handle growing long COVID cases
- Costs include healthcare burden, symptom management, and workforce losses
Frequently asked questions
What does the $8 billion long COVID cost estimate include?
According to The Conversation analysis, the estimate covers healthcare burden, managing symptoms, and loss to the workforce over a three-year period.
Why is the US healthcare system struggling with long COVID?
The Conversation source indicates that the US lacks the capacity to treat long COVID, and that HHS defunding is taking the country further away from being able to handle the growing number of cases.
As indicated by The Conversation analysis, the growing number of long COVID cases combined with inadequate treatment capacity and federal defunding presents significant challenges for managing both the clinical and economic impacts of this condition.
Was this article helpful?
Disclaimer. This article is health journalism intended for general information and education. It is not medical advice and is not a substitute for professional diagnosis or treatment. Always consult a qualified healthcare provider about your individual circumstances. Full disclaimer →
Related Coverage
Medically reviewed by Prof. Giorgi Pkhakadze, MD, MPH, PhD. Spotted an error? Contact the editorial team.
